Tag: Philips Healthcare
Philips signs an agreement with Cydar for Zenition
Royal Philips, a global leader in health technology, announced physicians will now have access to advanced new 3D image guidance capabilities through its image-guided...
Philips collaborates with leading institutes to ease surgery procedures
Royal Philips, a global leader in health technology, unveiled its vision for interventional medicine by bringing its breakthrough spectral CT imaging technology into a...
Philips launches new AI-enabled MR portfolio
Royal Philips, a global leader in health technology, today announced new AI-enabled innovations in MR imaging launching at the Radiological Society of North America (RSNA)...
Philips advances ultrasound portfolio
Royal Philips, a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for...
Philips — Expand its cardiac diagnostics
Royal Philips a global leader in health technology, today announced that it has signed an agreement to acquire Cardiologs, a France-based medical technology company...
Philips showcases integrated health informatics solutions during HIMSS21
Royal Philips, a global leader in health technology, showcased its latest intelligent, secure, interoperable technology. Collaborative informatics solutions virtually during the HIMSS21 Global Health...
Philips receives FDA approval for IVC filter removal device
Royal Philips, a global leader in health technology, announced the FDA has granted Breakthrough Device Designation (BDD) for a laser-assisted inferior vena cava (IVC)...
Healthcare’s digitization – Achieving true connected care
The Covid-19 pandemic sparked a global sense of urgency to pivot and adapt, causing the industry to rapidly increase the adoption of interoperable tools...
Five-year study confirms safety profile of Philips Stellarex .035” low-dose Drug-Coated...
Stellarex is the only Drug-Coated Balloon (DCB) to consistently demonstrate no difference in mortality every year through five years when compared with percutaneous transluminal...